 |
 |
 |
 |
 |
Treatments
The new pill (Sofosbuvir and Ledipasvir in one tablet) is the new hope for people in many countries that cannot afford the branded medicine. Gilead has signed agreements with a couple of pharmaceuticals companies in India to license them to produce a generic version of the Harvoni medicine. The process is running and expectations are that before the end of 2015 the Indian government will issue the permits to manufacture the generic version.
Many speculations has risen about the price, but the entire treatment of three months is expected to get into the market for a price around $1,000.
If you are looking for
Harvoni price online
this can be the opportunity to get the best prices of your hep c treatment.
Before contacting us please take into account that the medicine has to be prescribed by a doctor, and you must provide the prescription to us and we will verify it with your doctor.
We are able to deliver the Harvoni to almost every country in the world, directly to your doctor’s office or through a net of allied pharmacies.
If you are looking for
Viekira Pak price online
this can be the opportunity to get the best prices of your hep c treatment.
Before contacting us please take into account that the medicine has to be prescribed by a doctor, and you must provide the prescription to us and we will verify it with your doctor.
We are able to deliver the Viekira Pak to almost every country in the world, directly to your doctor’s office or through a net of allied pharmacies.
Sovaldi
is a once-daily oral nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen. Gilead states that it must be used with ribavirin or in combination with peginterferon alfa and ribavirin. Read more about Sovaldi
If you are looking for
Olysio price online
this can be the opportunity to get the best prices of your hep c treatment.
Before contacting us please take into account that the medicine has to be prescribed by a doctor, and you must provide the prescription to us and we will verify it with your doctor.
We are able to deliver the Olysio to almost every country in the world, directly to your doctor’s office or through a net of allied pharmacies.
VIEKIRA PAK™
is an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis. VIEKIRA PAK is the only FDA-approved regimen that contains three distinct mechanisms of action Read More About Viekira Pak
If you are looking for
Sovaldi price online
this can be the opportunity to get the best prices of your hep c treatment.
Before contacting us please take into account that the medicine has to be prescribed by a doctor, and you must provide the prescription to us and we will verify it with your doctor.
We are able to deliver the Sovaldi to almost every country in the world, directly to your doctor’s office or through a net of allied pharmacies.
There has been much news lately about the new versions of
Harvoni generic
been launched to the market. The true is that since 2013 Gilead has signed agreements with a number of pharmaceuticals to produce a generic version of its Harvoni Hep C treatment. The last agreement was signed with Natco Pharma Ltd an Indian pharmaceutical company that has received license to produce a generic version of Harvoni. These licenses limit the scope of the countries where the medicine can be sold; they have called “Access Program“ to this methodology that only allows selling the medicines in a limited number of countries (91 at this moment).
HARVONI
the first once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in adults. Gilead reports that the majority of patients can be cured with a once-daily pill in a period of 8 to 12 weeks. Read more about Harvoni
Daklinza® (daclatasvir)
for Treatment of Chronic Hepatitis C in the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza® (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus Read more about Daklinza
Checkout